Bath & Body Works, Inc. gears up to announce its third-quarter earnings on November 25, 2024. Analysts forecast an earnings per share (EPS) of $0.47, which indicates a decline of 4.2% compared to the previous year. However, revenue projections remain slightly positive, with expectations of a 1.1% increase, reaching around $1.58 billion.

Despite the anticipated drop in EPS, analysts have noted the stability in forecast changes over the past month, suggesting investors have a consistent grasp on future expectations. The company’s price-to-earnings (P/E) ratio stands at 7.29, reflecting its valuation and a commendable earnings yield of 13.73%.

Investors will be looking closely at Bath & Body Works as they evaluate its financial health. The price-to-sales ratio is about 0.91, indicating investors’ willingness to pay less than a dollar for each dollar of revenue. The enterprise value to sales ratio of 1.57 highlights the company’s total valuation in relation to its revenues, reinforcing its positioning within the marketplace. The current ratio of 1.11 suggests it can cover its short-term liabilities, signifying financial stability.